BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Antibe Announces Results of 2023 Annual Meeting

  Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation therapies to target inflammation, is pleased to announce the results of its annual meeting of shareholders (the “Meeting”) held earlier today.

  September 8, 2023

   · 

  1 min read
• Policy

  FDA Roundup: September 8, 2023

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

  September 8, 2023

   · 

  5 min read
• Prime Minister of the Republic of Serbia Visits SK bioscience to Establish Partnership for Vaccine Localization

  SK bioscience announced that Ana Brnabić, Prime Minister of the Republic of Serbia has visited the SK bioscience headquarters and signed a memorandum of understanding with the company to establish a strategic partnership in vaccine development and manufacturing between the two countries.

  September 8, 2023

   · 

  4 min read
• Pharm Country

  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - September 08, 2023

  Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to 13 new employees.

  September 8, 2023

   · 

  2 min read
• BioCapital

  Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference

  Elutia Inc. today announced that Dr. Randy Mills, President and Chief Executive Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference.

  September 8, 2023

   · 

  1 min read
• Drug Development

  Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine

  Parion Sciences Inc. today announced publication in The Lancet Respiratory Medicine of positive results of the Phase 2 study of idrevloride in hypertonic saline in people with primary ciliary dyskinesia (PCD).

  September 8, 2023

   · 

  5 min read
• Deals

  Coherus Completes Surface Oncology Acquisition

  Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the closing of the previously announced acquisition of Surface Oncology, Inc.

  September 8, 2023

   · 

  7 min read
• Biotech Bay

  Kyverna Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

  Kyverna Therapeutics (“Kyverna”), announced today its participation in the Morgan Stanley 21st Annual Global Healthcare Conference to be held in New York, NY, on September 11-13, 2023.

  September 8, 2023

   · 

  1 min read
• Business

  World-Renowned Scientist and Researcher Yaron Tomer, MD, named the Marilyn and Stanley M. Katz Dean at Einstein

  Yaron Tomer, MD, has been named the Marilyn and Stanley M. Katz Dean at the Albert Einstein College of Medicine, effective October 2nd, 2023.

  September 8, 2023

   · 

  5 min read
• Business

  AbbVie Declares Quarterly Dividend - September 08, 2023

  The board of directors of AbbVie Inc. declared a quarterly cash dividend of $1.48 per share.

  September 8, 2023

   · 

  1 min read